Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

Recruiting N/A Interventional Study
Anticoagulants and Bleeding Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
30 (estimated)
Sponsor
Centre Hospitalier Régional d'Orléans · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal is to investigate whether blood samples drawn from a central venous catheter can provide reliable measurements of unfractionated heparin (UFH) anti-Xa activity, compared to the standard method of peripheral vein puncture, in intensive care unit (ICU) patients receiving continuous intravenous UFH. To evaluate the reliability of central venous blood sampling, the study will compare anti-Xa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Person (or support person/relative if unable to do so) who has agreed to participate in the study * 18 years of age or older * Hospitalized in intensive care medicine * Having a central venous catheter with at least three lumens (internal jugular, subclavian or femoral) alread…
Contacts

Gregoire MULLER, Dr

+33238229534

gregoire.muller@chu-orleans.fr

CONTACT